Atlas Trials

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Clinical trial NCT00455936 · COMPLETED

Trial details

NCT number
NCT00455936
Sponsor
National Cancer Center, Korea
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2005-10-01
Primary completion
2009-11-01
Enrollment
315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.